Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Guerci

Showing results (41-50 of 113) with videos related to

Pageof 12
Sort By:
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 20, 2021
Immunoglobulin Preparations Can Mislead Clinical Decision-Making in Follow-Up of Differentiated Thyroid CancerMélissa Yéléhé-Okouma, Catherine Malaplate, Nadine Petitpain, et al.
Diabetes Technology & Therapeutics|June 17, 2024
Reduced Rate of Hospitalizations for Acute Diabetes Events Before and After FreeStyle Libre<sup>®</sup> System Initiation in Some People With Type 2 Diabetes on Insulin-Secretagogue Oral Drug Therapy Without Insulin in FranceJean-Pierre Riveline, Fleur Levrat-Guillen, Bruno Detournay, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 17, 2021
Treatment Patterns and Persistence With GLP-1 RA Treatments Among Patients With Type 2 Diabetes in France: A Retrospective Cohort AnalysisSarah Zimner Rapuch, Victoria Divino, Kirsi Norrbacka, et al.
Diabetes Technology & Therapeutics|March 21, 2023
Reduced Acute Diabetes Events After FreeStyle Libre System Initiation in People 65 Years or Older with Type 2 Diabetes on Intensive Insulin Therapy in FranceBruno Guerci, Fleur Levrat-Guillen, Eric Vicaut, et al.
Diabetes Care|February 24, 2012
Safety and efficacy of once-weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes over 84 weeksMichaela Diamant, Luc Van Gaal, Stephen Stranks, et al.
Diabetes Technology & Therapeutics|September 12, 2022
Important Decrease in Hospitalizations for Acute Diabetes Events Following FreeStyle Libre System Initiation in People with Type 2 Diabetes on Basal Insulin Therapy in FranceBruno Guerci, Ronan Roussel, Fleur Levrat-Guillen, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 21, 2018
Treatment Intensification in Type 2 Diabetes: A Real-World Study of 2-OAD Regimens, GLP-1 RAs, or Basal InsulinLawrence Blonde, Denis Raccah, Elisheva Lew, et al.
The Lancet. Diabetes & Endocrinology|April 16, 2014
Exenatide once weekly versus insulin glargine for type 2 diabetes (DURATION-3): 3-year results of an open-label randomised trialMichaela Diamant, Luc Van Gaal, Bruno Guerci, et al.
Diabetes Care|April 21, 2021
Important Drop in Rate of Acute Diabetes Complications in People With Type 1 or Type 2 Diabetes After Initiation of Flash Glucose Monitoring in France: The RELIEF StudyRonan Roussel, Jean-Pierre Riveline, Eric Vicaut, et al.
Diabetes Research and Clinical Practice|February 9, 2020
The burden of type 2 diabetes in Europe: Current and future aspects of insulin treatment from patient and healthcare spending perspectivesAntonio Ceriello, Harold W deValk, Bruno Guerci, et al.
Pageof 12

Showing results (41-50 of 113) with videos related to

Sort By:
Pageof 12
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 20, 2021
Immunoglobulin Preparations Can Mislead Clinical Decision-Making in Follow-Up of Differentiated Thyroid CancerMélissa Yéléhé-Okouma, Catherine Malaplate, Nadine Petitpain, et al.
Diabetes Technology & Therapeutics|June 17, 2024
Reduced Rate of Hospitalizations for Acute Diabetes Events Before and After FreeStyle Libre<sup>®</sup> System Initiation in Some People With Type 2 Diabetes on Insulin-Secretagogue Oral Drug Therapy Without Insulin in FranceJean-Pierre Riveline, Fleur Levrat-Guillen, Bruno Detournay, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 17, 2021
Treatment Patterns and Persistence With GLP-1 RA Treatments Among Patients With Type 2 Diabetes in France: A Retrospective Cohort AnalysisSarah Zimner Rapuch, Victoria Divino, Kirsi Norrbacka, et al.
Diabetes Technology & Therapeutics|March 21, 2023
Reduced Acute Diabetes Events After FreeStyle Libre System Initiation in People 65 Years or Older with Type 2 Diabetes on Intensive Insulin Therapy in FranceBruno Guerci, Fleur Levrat-Guillen, Eric Vicaut, et al.
Diabetes Care|February 24, 2012
Safety and efficacy of once-weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes over 84 weeksMichaela Diamant, Luc Van Gaal, Stephen Stranks, et al.
Diabetes Technology & Therapeutics|September 12, 2022
Important Decrease in Hospitalizations for Acute Diabetes Events Following FreeStyle Libre System Initiation in People with Type 2 Diabetes on Basal Insulin Therapy in FranceBruno Guerci, Ronan Roussel, Fleur Levrat-Guillen, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 21, 2018
Treatment Intensification in Type 2 Diabetes: A Real-World Study of 2-OAD Regimens, GLP-1 RAs, or Basal InsulinLawrence Blonde, Denis Raccah, Elisheva Lew, et al.
The Lancet. Diabetes & Endocrinology|April 16, 2014
Exenatide once weekly versus insulin glargine for type 2 diabetes (DURATION-3): 3-year results of an open-label randomised trialMichaela Diamant, Luc Van Gaal, Bruno Guerci, et al.
Diabetes Care|April 21, 2021
Important Drop in Rate of Acute Diabetes Complications in People With Type 1 or Type 2 Diabetes After Initiation of Flash Glucose Monitoring in France: The RELIEF StudyRonan Roussel, Jean-Pierre Riveline, Eric Vicaut, et al.
Diabetes Research and Clinical Practice|February 9, 2020
The burden of type 2 diabetes in Europe: Current and future aspects of insulin treatment from patient and healthcare spending perspectivesAntonio Ceriello, Harold W deValk, Bruno Guerci, et al.
Pageof 12